Health ProductsType I recall

JAMP Venlafaxine XR 37.5 mg capsules; Mislabelling

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: JAMP Venlafaxine XR 37.5 mg capsules
Issue: Health products - Labelling
What to do: Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If it contains 150 mg capsules, or if you are unsure, return it to your pharmacy as soon as possible. Your pharmacist will check it and provide a replacement with the correct capsules, if needed. Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache.
Audience: General public, Healthcare, Industry
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

BrandProduct NameMarket AuthorizationDosage FormLot numberStrength
Jamp PharmaVenlafaxine 37.5 mg capsuleDIN 02516535Capsule (extended release)PTC5140AVenlafaxine hydrochloride 37.5 mg

Issue

An incorrect label (Venlafaxine XR 37.5 mg) is attached to some units of the affected lot which contains: Venlafaxine XR 150 mg.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime